Clinical trial
A Phase 2 Trial of Ixazomib for Kaposi Sarcoma
NCT04305691 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2 Trial of Ixazomib for Kaposi Sarcoma
- Lead sponsor
- AIDS Malignancy Consortium
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- November 7, 2023
- Completion date
- March 15, 2029
- Enrollment
- 41 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
kaposi sarcoma, skin